A detailed history of Profund Advisors LLC transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 16,401 shares of STOK stock, worth $185,659. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,401
Previous 14,893 10.13%
Holding current value
$185,659
Previous $201,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$12.24 - $15.92 $18,457 - $24,007
1,508 Added 10.13%
16,401 $201,000
Q2 2024

Aug 13, 2024

BUY
$11.03 - $17.52 $164,269 - $260,925
14,893 New
14,893 $201,000

Others Institutions Holding STOK

About Stoke Therapeutics, Inc.


  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $446M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.